ACTIVE

HERCOMEX

Export PDF

Financial year 2025 · closed on 30/06/2025

Net result

5,8 k €

-85.3% YoY

Gross margin

211,3 k €

-17.6% YoY

Equity

225,4 k €

+1.9% YoY

Workforce

2,8 ETP

0.0% YoY

What does HERCOMEX do?

HERCOMEX is a Private limited company incorporated in 1993. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Jurbise. It employs on average 2,8 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0450.733.066

Incorporation

19/08/1993

Legal form

Private limited company

Registered office

Rue d'Erbisoeul(H) 244
7050 Jurbise · WallonieSee on map

Contributed capital

63 000,00 €

Latest accounts

30/06/2025

Average workforce

2,8 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007
Income statement
Gross margin	211,3 k €	-17.6%	256,5 k €	+14.2%	224,5 k €	+10.6%	203 k €	+13.0%	179,6 k €	-0.9%	181,2 k €	-13.8%	210,2 k €	+24.7%	168,6 k €	-26.0%	227,8 k €	+16.7%	195,2 k €	+5.9%	184,2 k €	+3.0%	178,9 k €	+26.4%	141,5 k €	-19.8%	176,4 k €	+3.7%	170,1 k €	+10.3%	154,2 k €	-4.8%	162 k €	+17.2%	138,3 k €	-0.7%	139,2 k €
EBITDA	40,3 k €	-58.2%	96,3 k €	+49.1%	64,6 k €	+7.4%	60,2 k €	+70.2%	35,3 k €	-24.2%	46,6 k €	-23.1%	60,6 k €	+164%	22,9 k €	-28.6%	32,1 k €	-10.2%	35,8 k €	+13.3%	31,6 k €	+71.0%	18,5 k €	-15.8%	21,9 k €	-35.0%	33,8 k €	-36.1%	52,8 k €	+35.6%	38,9 k €	-29.2%	55 k €	+2.6%	53,6 k €	+2.0%	52,6 k €
Operating result	16,2 k €	-76.3%	68,3 k €	+83.4%	37,2 k €	+11.8%	33,3 k €	+265%	9,1 k €	-55.3%	20,4 k €	-39.3%	33,6 k €	+195%	11,4 k €	-52.4%	23,9 k €	-13.2%	27,6 k €	+18.0%	23,4 k €	+130%	10,1 k €	-22.0%	13 k €	-33.2%	19,5 k €	-50.3%	39,1 k €	+59.5%	24,5 k €	-41.4%	41,9 k €	+2.7%	40,8 k €	-9.2%	44,9 k €
Net result	5,8 k €	-85.3%	39,3 k €	+82.4%	21,5 k €	+8.2%	19,9 k €	+377%	4,2 k €	-62.0%	11 k €	-55.6%	24,7 k €	+393%	5 k €	-55.7%	11,3 k €	-13.6%	13,1 k €	+58.2%	8,3 k €	+112%	3,9 k €	-3.4%	4 k €	+1462%	259,1 €	-98.5%	16,7 k €	+54.9%	10,8 k €	-43.9%	19,3 k €	-40.0%	32,1 k €	-12.6%	36,7 k €
Balance sheet
Equity	225,4 k €	+1.9%	221,3 k €	+20.5%	183,7 k €	+13.3%	162,2 k €	+14.0%	142,3 k €	+3.0%	138,1 k €	+8.6%	127,1 k €	+24.1%	102,4 k €	+5.1%	97,4 k €	+13.1%	86,1 k €	+17.9%	73 k €	+12.8%	64,7 k €	+6.4%	60,8 k €	+7.1%	56,8 k €	+0.5%	56,5 k €	+42.1%	39,8 k €	+37.3%	29 k €	+198%	9,7 k €	+143%	-22,4 k €
Total assets	591,9 k €	-6.9%	635,6 k €	+11.2%	571,6 k €	+0.4%	569,3 k €	-5.1%	599,6 k €	-4.3%	626,6 k €	-12.8%	718,6 k €	+34.0%	536,2 k €	+9.7%	488,8 k €	-0.2%	489,6 k €	+13.6%	430,9 k €	+15.7%	372,5 k €	-7.7%	403,4 k €	-7.7%	437,1 k €	+9.8%	397,9 k €	-6.8%	427,1 k €	+1.0%	422,8 k €	-7.7%	458 k €	+20.0%	381,6 k €
Cash	58,2 k €	-34.5%	88,8 k €	+12.1%	79,2 k €	+43.7%	55,1 k €	+27.9%	43,1 k €	-11.9%	48,9 k €	-42.3%	84,8 k €	+22.0%	69,5 k €	-8.7%	76,1 k €	-20.9%	96,2 k €	+90.5%	50,5 k €	+11.0%	45,5 k €	+13.1%	40,2 k €	-56.5%	92,6 k €	+19.7%	77,3 k €	+32.3%	58,5 k €	+39.5%	41,9 k €	-56.6%	96,5 k €	+184%	34 k €
Debts	366,5 k €	-11.5%	414,3 k €	+6.8%	387,9 k €	-4.7%	407,1 k €	-11.0%	457,3 k €	-6.4%	488,5 k €	-17.4%	591,5 k €	+36.4%	433,7 k €	+10.8%	391,4 k €	-3.0%	403,5 k €	+12.7%	357,9 k €	+16.3%	307,8 k €	-10.2%	342,5 k €	-9.6%	379 k €	+11.0%	341,4 k €	-11.9%	387,3 k €	-1.6%	393,8 k €	-12.2%	448,3 k €	+11.4%	402,4 k €
Other
Workforce	2,8 ETP	0.0%	2,8 ETP	0.0%	2,8 ETP	-3.4%	2,9 ETP	0.0%	2,9 ETP	+3.6%	2,8 ETP	-6.7%	3,0 ETP	+3.4%	2,9 ETP	-27.5%	4,0 ETP	+8.1%	3,7 ETP	+12.1%	3,3 ETP	-15.4%	3,9 ETP	+50.0%	2,6 ETP	-3.7%	2,7 ETP	+3.8%	2,6 ETP	-3.7%	2,7 ETP	0.0%	2,7 ETP	+3.8%	2,6 ETP	+44.4%	1,8 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 30/06/2025 · 2 active · 21 ended

Active mandates

Jocelyne Leterme

Director

Active

PHARMGETH

Director · 0471.524.819

Represented by Vansteelant Filip

Active

Ended mandates

Filip Octaaf Vansteelant

Director · since 28 août 2020 · until 06 décembre 2025

Ended

Filip Octaaf Vansteelant

Managing director · since 28 août 2020 · until 06 juin 2025

Ended

Filip Vansteelant

Managing director · since 28 août 2020 · until 06 décembre 2025

Ended

Jocelyne Leterme

Director · since 28 août 2020 · until 06 juin 2025

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/07/2024	01/07/2023	01/07/2022	01/07/2021	01/07/2020	01/07/2019
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	30/06/2022	30/06/2021	30/06/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	31/01/2026	03/02/2025	31/01/2024	31/01/2023	31/01/2022	02/02/2021
General meeting	06/12/2025	07/12/2024	02/12/2023	03/12/2022	04/12/2021	05/12/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/06/2025	06/12/2025	31/01/2026	French	PDF
Abridged model	30/06/2024	07/12/2024	03/02/2025	French	PDF
Abridged model	30/06/2023	02/12/2023	31/01/2024	French	PDF
Abridged model	30/06/2022	03/12/2022	31/01/2023	French	PDF
Abridged model	30/06/2021	04/12/2021	31/01/2022	French	PDF
Abridged model	30/06/2020	05/12/2020	02/02/2021	French	PDF
Abridged model	30/06/2019	07/12/2019	15/01/2020	French	PDF
Abridged model	30/06/2018	01/12/2018	14/01/2019	French	PDF
Abridged model	30/06/2017	02/12/2017	15/01/2018	French	PDF
Abridged model	31/03/2016	26/08/2016	30/09/2016	French	PDF
Abridged model	31/03/2015	28/08/2015	29/09/2015	French	PDF
Abridged model	31/03/2014	29/08/2014	02/10/2014	French	PDF
Abridged model	31/03/2013	30/08/2013	18/10/2013	French	PDF
Abridged model	31/03/2012	31/08/2012	30/10/2012	French	PDF
Abridged model	31/03/2011	26/08/2011	09/11/2011	French	PDF
Abridged model	31/03/2010	27/08/2010	15/11/2010	French	PDF
Abridged model	31/03/2009	28/08/2009	26/11/2009	French	PDF
Abridged model	31/03/2008	29/08/2008	07/12/2008	French	PDF
Abridged model	31/03/2007	31/08/2007	31/10/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 30/06/2025 · 2 active · 21 ended

Active mandates

Jocelyne Leterme

Director

Active

PHARMGETH

Director · 0471.524.819

Represented by Vansteelant Filip

Active

Ended mandates

Filip Octaaf Vansteelant

Director · since 28 août 2020 · until 06 décembre 2025

Ended

Filip Octaaf Vansteelant

Managing director · since 28 août 2020 · until 06 juin 2025

Ended

Filip Vansteelant

Managing director · since 28 août 2020 · until 06 décembre 2025

Ended

Jocelyne Leterme

Director · since 28 août 2020 · until 06 juin 2025

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates05/04/2024
DEMISSIONS, NOMINATIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE
PDF
Other17/01/2017
OBJET - ASSEMBLEE GENERALE - ANNEE COMPTABLE
PDF
Mandates22/12/2014
DEMISSIONS, NOMINATIONS
PDF
Capital / shares23/01/2012
CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, )
PDF
Mandates28/02/2011
DEMISSIONS, NOMINATIONS
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 20255,8 k €↓
2024
Annual accounts 202439,3 k €↑
2023
Annual accounts 202321,5 k €↑
2022
Annual accounts 202219,9 k €↑
2021
Annual accounts 20214,2 k €↓
2020
Annual accounts 202011 k €↓
2019
Annual accounts 201924,7 k €↑
2018
Annual accounts 20185 k €↓
2017
Annual accounts 201711,3 k €↓
2016
Annual accounts 201613,1 k €↑
2015
Annual accounts 20158,3 k €↑
2014
Annual accounts 20143,9 k €↓
2013
Annual accounts 20134 k €↑
2012
Annual accounts 2012259,1 €↓
2011
Annual accounts 201116,7 k €↑
2010
Annual accounts 201010,8 k €↓
2009
Annual accounts 200919,3 k €↓
2008
Annual accounts 200832,1 k €↓
2007
Annual accounts 200736,7 k €
19/08/1993
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

HERCOMEX

Overview

What does HERCOMEX do?

Trend over 19 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline